ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,639Medicare Part D Prescriptions Filled, Including Refills

Rank: 185 out of 676

$524K Total Retail Price of All Prescriptions

Rank: 207 out of 676

530 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 530 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 9,308 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
AMLODIPINE BESYLATE 719 604 1 3
LEVOTHYROXINE SODIUM 624 525 2 7
METFORMIN HCL 401 313 3 8
CITALOPRAM HBR 341 271 4 17
OMEPRAZOLE 318 281 5 2
ZOLPIDEM TARTRATE 310 223 6 21
SIMVASTATIN 309 247 7 6
HYDROCODONE-ACETAMINOPHEN 263 221 S3 8 1
TRAMADOL HCL 234 180 9 19
PANTOPRAZOLE SODIUM 217 179 10 42
GLIMEPIRIDE 216 192 11 30
FUROSEMIDE 209 173 12 4
LISINOPRIL 205 186 13 5
BENAZEPRIL HCL 202 168 14 58
DIOVAN 166 140 15 37
PRAVASTATIN SODIUM 163 118 16 11
POTASSIUM CHLORIDE 158 129 17 9
ENALAPRIL MALEATE 147 124 18 65
ATENOLOL 142 141 19 25
WARFARIN SODIUM 131 97 20 18
LOSARTAN POTASSIUM 127 114 21 34
SYNTHROID 125 93 22 48
HYDROCHLOROTHIAZIDE 123 106 23 12
GABAPENTIN 121 90 24 10
METOPROLOL TARTRATE 118 95 25 22
KLOR-CON M20 117 73 26 67
MELOXICAM 115 80 27 13
ATORVASTATIN CALCIUM 111 101 28 20
METOPROLOL SUCCINATE 110 92 29 14
ALLOPURINOL 108 92 30 31
KLOR-CON 10 107 75 31 95
TRAZODONE HCL 98 92 32 36
CRESTOR 97 86 33 29
NEXIUM 95 71 34 23
AZITHROMYCIN 95 77 34 39
AMLODIPINE BESYLATE-BENAZEPRIL 88 88 36 44
CLOPIDOGREL 82 75 37 28
LANTUS 78 63 38 55
CLONIDINE HCL 76 64 39 32
ADVAIR DISKUS 73 38 40 87
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 47 41 16
ALENDRONATE SODIUM 69 49 42 61
SERTRALINE HCL 67 46 43 26
LANTUS SOLOSTAR 63 42 44 169
CARVEDILOL 62 56 45 15
ESCITALOPRAM OXALATE 60 50 46 73
ISOSORBIDE MONONITRATE ER 59 47 47 54
BENICAR 59 59 47 218
TAMSULOSIN HCL 57 41 49 38
NAMENDA 55 48 50 35
AMITRIPTYLINE HCL 55 44 R 50 46
DONEPEZIL HCL 54 54 52 24
PREDNISONE 53 52 53 53
DEXILANT 52 32 54 155
PLAVIX 51 45 55 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.